Global Strain and Mechanical Dispersion May Predict Death and Ventricular Arrhythmias Better Than Ejection Fraction

Launched by OSLO UNIVERSITY HOSPITAL · Nov 5, 2014

Keywords

ClinConnect Summary

This clinical trial is studying whether certain heart measurements, called global strain and mechanical dispersion, can better predict serious heart events, like death and dangerous heart rhythms, compared to the traditional measurement known as ejection fraction (EF). The study is focused on patients who have experienced a heart attack and have heart failure, regardless of the cause. Researchers believe that these new measurements might provide more accurate information about a patient's heart health.

To participate in this trial, you should be an adult over 18 years old who has had a heart attack and is showing signs of heart failure. You also need to be scheduled to receive a special device called an implantable cardioverter-defibrillator (ICD) to help prevent life-threatening heart rhythms. If you join, you will help researchers learn more about heart health and may contribute to better treatments for others in the future. The trial is currently recruiting participants, and your involvement could make a significant difference in understanding how to care for patients with heart issues.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • All patients with
• • 1. myocardial infarction
• • 2. heart failure( defined as heart failure symptoms: reduced left ventricular function/ and or heart failure signs on chest x ray.
• • 3. planned for primary prophylactic ICD
• • over 18 years of age
• • Informed consent
• Exclusion Criteria:
• • -